Diabetology: Feature Papers 2022
As Editor-in-Chief of the journal Diabetology, I am pleased to announce that the Special Issue "Diabetology: Feature Papers 2022" has now been published as a reprint. Diabetology (ISSN 2673-4540) is an international, peer-reviewed scientific open access journal that provides an advanced fo...
Saved in:
| Other Authors: | |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_100058 | ||
| 005 | 20230511 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20230511s2023 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-7257-4 | ||
| 020 | |a 9783036572567 | ||
| 020 | |a 9783036572574 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-0365-7257-4 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a M |2 bicssc | |
| 072 | 7 | |a MJ |2 bicssc | |
| 100 | 1 | |a Clifton, Peter |4 edt | |
| 700 | 1 | |a Clifton, Peter |4 oth | |
| 245 | 1 | 0 | |a Diabetology: Feature Papers 2022 |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
| 300 | |a 1 electronic resource (156 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a As Editor-in-Chief of the journal Diabetology, I am pleased to announce that the Special Issue "Diabetology: Feature Papers 2022" has now been published as a reprint. Diabetology (ISSN 2673-4540) is an international, peer-reviewed scientific open access journal that provides an advanced forum for studies related to the epidemiology, etiology, pathophysiology, pathogenesis, management, complications, and prevention of diabetes, including the molecular, biochemical, and physiological aspects of diabetes. In this Special Issue, "Feature Papers", we aimed to publish outstanding contributions in the main fields covered by the journal, which will make a great contribution to the community. This reprint covers the whole spectrum of diabetology from risk screening, risk markers, pathways of disease in type 1 diabetes and insulin treatment, and management of the disease and comorbidities. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 650 | 7 | |a Clinical & internal medicine |2 bicssc | |
| 653 | |a older people | ||
| 653 | |a diabetes mellitus | ||
| 653 | |a management | ||
| 653 | |a insulin therapy | ||
| 653 | |a frailty | ||
| 653 | |a sarcopenia | ||
| 653 | |a type 1 diabetes | ||
| 653 | |a type 2 diabetes | ||
| 653 | |a insulin | ||
| 653 | |a beta cell preservation | ||
| 653 | |a verapamil | ||
| 653 | |a thioredoxin-interacting protein (TXNIP) | ||
| 653 | |a Chronic Care Model | ||
| 653 | |a self-management of type 2 diabetes | ||
| 653 | |a chronic disease | ||
| 653 | |a healthcare system of Pakistan | ||
| 653 | |a patients' quality of life | ||
| 653 | |a obstructive sleep apnoea | ||
| 653 | |a DM | ||
| 653 | |a obesity | ||
| 653 | |a inflammation | ||
| 653 | |a polysomnography | ||
| 653 | |a coronavirus disease 2019 | ||
| 653 | |a COVID-19 | ||
| 653 | |a severe acute respiratory syndrome coronavirus 2 | ||
| 653 | |a SARS-CoV-2 | ||
| 653 | |a diabetes | ||
| 653 | |a diabetic ketoacidosis | ||
| 653 | |a DKA | ||
| 653 | |a hyperglycemia | ||
| 653 | |a mortality | ||
| 653 | |a innate immunity | ||
| 653 | |a cytokine storm | ||
| 653 | |a angiotensin-converting enzyme 2 | ||
| 653 | |a pancreatic β-cell damage | ||
| 653 | |a pediatrics | ||
| 653 | |a HbA1c | ||
| 653 | |a telemedicine | ||
| 653 | |a continuous glucose monitoring | ||
| 653 | |a prediabetes | ||
| 653 | |a liver enzymes | ||
| 653 | |a rhenium (V) compound | ||
| 653 | |a triglycerides | ||
| 653 | |a NAFLD | ||
| 653 | |a fructose | ||
| 653 | |a injection technique | ||
| 653 | |a lipohypertrophy | ||
| 653 | |a sodium glucose co-transporter 2 (SGLT2) inhibitors | ||
| 653 | |a nocturia | ||
| 653 | |a sodium intake | ||
| 653 | |a key informant interviews | ||
| 653 | |a prevention of type 2 diabetes | ||
| 653 | |a National DPP | ||
| 653 | |a DSMES | ||
| 653 | |a telehealth | ||
| 653 | |a provider experiences | ||
| 653 | |a lipodystrophy | ||
| 653 | |a clinical detection | ||
| 653 | |a recommendations | ||
| 653 | |a rehabilitation | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/7151 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/100058 |7 0 |z DOAB: description of the publication |